Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Campbell

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Investigational New Drugs|January 24, 2004
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignanciesJoseph P Eder, Rocio Garcia-Carbonero, Jeffrey W Clark, et al.
Plos One|July 13, 2017
Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South AfricaMatthew J Magee, Yan V Sun, James C M Brust, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2019
The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse EventsJonathan P Smith, Neel R Gandhi, N Sarita Shah, et al.
Plos One|October 14, 2017
Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South AfricaThandi Kapwata, Natashia Morris, Angela Campbell, et al.
Plos Neglected Tropical Diseases|October 12, 2020
Adults from Kisumu, Kenya have robust γδ T cell responses to Schistosoma mansoni, which are modulated by tuberculosisTaryn A McLaughlin, Jeremiah Khayumbi, Joshua Ongalo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
A phase I dose-escalation and pharmacokinetic study of brostallicin (PNU-166196A), a novel DNA minor groove binder, in adult patients with advanced solid tumorsA Craig Lockhart, Martin Howard, Kenneth R Hande, et al.
Immunohorizons|October 3, 2020
Activation-Induced Marker Expression Identifies <i>Mycobacterium tuberculosis</i>-Specific CD4 T Cells in a Cytokine-Independent Manner in HIV-Infected Individuals with Latent TuberculosisMorgan S Barham, Wendy E Whatney, Jeremiah Khayumbi, et al.
Frontiers in Immunology|September 10, 2019
HIV Infection Is Associated With Downregulation of BTLA Expression on <i>Mycobacterium tuberculosis</i>-Specific CD4 T Cells in Active Tuberculosis DiseaseMorgan S Barham, Deborah A Abrahams, Jeremiah Khayumbi, et al.
The European Respiratory Journal|August 18, 2018
Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communitiesSara C Auld, N Sarita Shah, Barun Mathema, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South AfricaJames C M Brust, N Sarita Shah, Koleka Mlisana, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Investigational New Drugs|January 24, 2004
A phase I trial of daily oral 4'- N -benzoyl-staurosporine in combination with protracted continuous infusion 5-fluorouracil in patients with advanced solid malignanciesJoseph P Eder, Rocio Garcia-Carbonero, Jeffrey W Clark, et al.
Plos One|July 13, 2017
Polymorphisms in the vitamin D receptor gene are associated with reduced rate of sputum culture conversion in multidrug-resistant tuberculosis patients in South AfricaMatthew J Magee, Yan V Sun, James C M Brust, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 7, 2019
The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse EventsJonathan P Smith, Neel R Gandhi, N Sarita Shah, et al.
Plos One|October 14, 2017
Spatial distribution of extensively drug-resistant tuberculosis (XDR TB) patients in KwaZulu-Natal, South AfricaThandi Kapwata, Natashia Morris, Angela Campbell, et al.
Plos Neglected Tropical Diseases|October 12, 2020
Adults from Kisumu, Kenya have robust γδ T cell responses to Schistosoma mansoni, which are modulated by tuberculosisTaryn A McLaughlin, Jeremiah Khayumbi, Joshua Ongalo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
A phase I dose-escalation and pharmacokinetic study of brostallicin (PNU-166196A), a novel DNA minor groove binder, in adult patients with advanced solid tumorsA Craig Lockhart, Martin Howard, Kenneth R Hande, et al.
Immunohorizons|October 3, 2020
Activation-Induced Marker Expression Identifies <i>Mycobacterium tuberculosis</i>-Specific CD4 T Cells in a Cytokine-Independent Manner in HIV-Infected Individuals with Latent TuberculosisMorgan S Barham, Wendy E Whatney, Jeremiah Khayumbi, et al.
Frontiers in Immunology|September 10, 2019
HIV Infection Is Associated With Downregulation of BTLA Expression on <i>Mycobacterium tuberculosis</i>-Specific CD4 T Cells in Active Tuberculosis DiseaseMorgan S Barham, Deborah A Abrahams, Jeremiah Khayumbi, et al.
The European Respiratory Journal|August 18, 2018
Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communitiesSara C Auld, N Sarita Shah, Barun Mathema, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Improved Survival and Cure Rates With Concurrent Treatment for Multidrug-Resistant Tuberculosis-Human Immunodeficiency Virus Coinfection in South AfricaJames C M Brust, N Sarita Shah, Koleka Mlisana, et al.
Pageof 7